Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
drug delivery
Pharma
Recurv raises $24M to take nano-emulsion taxane to clinical POC
Recurv has created a candidate, RP-001, designed to focus taxane delivery on the tumor and thereby reduce its impact on healthy tissues.
Nick Paul Taylor
Feb 3, 2023 7:30am
Investors kibosh Midatech merger, triggering scramble for cash
Jan 24, 2023 10:08am
Loading mRNA into extracellular vesicles limits wrinkles in mice
Jan 17, 2023 10:15am
Biogen bets $10M on implant to improve delivery of Spinraza
Jan 10, 2023 7:25am
Mayo, InSitu pen prolonged-release cancer co-development pact
Jan 3, 2023 7:15am
Midatech plots pivot beyond delivery tech with Bioasis buyout
Dec 20, 2022 7:40am